Skip to main content

Advertisement

Log in

Idiopathic Pericarditis—an Autoinflammatory Disease?

  • Orphan Diseases (B Manger, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of the Review

Idiopathic acute and recurrent pericarditis are rare diseases of unknown origin. Here, we review trigger factors, pathomechanism, and treatment options for acute and recurrent pericarditis.

Recent Findings

Acute pericarditis can be triggered by viral infections, myocardial ischemia, heart catheter interventions, cardiac surgery or seem to occur without any trigger. Earlier reports about viral nucleic acids in the effusion or myocardial autoantibodies in serum were detected only in a minority of patients. The current pathomechanistic concept focuses on the innate immune system. Clinical trials revealed that colchicine and anti-IL1β-targeted medication were effective to control acute and recurrent attacks.

Summary

Activation of the innate immune system in pericarditis suggests that autoinflammation contributes to acute and recurrent pericarditis. The efficacy of colchicine and anti-IL1β-targeted medication in clinical trials indicates that acute and recurrent pericarditis should be regarded as an autoinflammatory disease. Therefore, idiopathic pericarditis should be considered as an autoinflammatory disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93. https://doi.org/10.4065/mcp.2010.0046.

    Article  PubMed  PubMed Central  Google Scholar 

  2. • Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. ESC scientific document group. Eur Heart J. 2015;36(42):2921–64. https://doi.org/10.1093/eurheartj/ehv318 These guidelines describe the current recommendations for diagnosis and management of pericarditis.

    Article  PubMed  Google Scholar 

  3. Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042–6. https://doi.org/10.1016/j.jacc.2003.09.055.

    Article  PubMed  Google Scholar 

  4. Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation. 2013;127(16):1723–6. https://doi.org/10.1161/CIRCULATIONAHA.111.066365.

    Article  PubMed  Google Scholar 

  5. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–28. https://doi.org/10.1161/CIRCULATIONAHA.108.844753.

    Article  PubMed  Google Scholar 

  6. Pankuweit S, Stein A, Karatolios K, Richter A, Ruppert V, Maisch B. Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions. Heart Fail Rev. 2013;18(3):329–36. https://doi.org/10.1007/s10741-013-9375-x.

    Article  CAS  PubMed  Google Scholar 

  7. He Y, Sawalha AH. Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol. 2018;30(5):490–7. https://doi.org/10.1097/BOR.0000000000000522.

    Article  CAS  PubMed  Google Scholar 

  8. Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013;168(2):648–52. https://doi.org/10.1016/j.ijcard.2012.09.052.

    Article  PubMed  Google Scholar 

  9. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–13. https://doi.org/10.7326/0003-4819-77-4-507.

    Article  CAS  PubMed  Google Scholar 

  10. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M, Ribas MC. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med. 2004;116:417–20. https://doi.org/10.1016/j.amjmed.2003.11.008.

    Article  CAS  PubMed  Google Scholar 

  11. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73(7):1211–20 https://www.aafp.org/afp/2006/0401/p1211.html.

    PubMed  Google Scholar 

  12. Light RW. The Light criteria: the beginning and why they are useful 40 years later. Clin Chest Med. 2013;34(1):21–6. https://doi.org/10.1016/j.ccm.2012.11.006.

    Article  PubMed  Google Scholar 

  13. • Bielsa S, Corral E, Bagüeste P, Porcel JM. Characteristics of pleural effusions in acute idiopathic pericarditis and post-cardiac injury syndrome. Ann Am Thorac Soc. 2016;13(2):298–300. https://doi.org/10.1513/AnnalsATS.201510-668LE This study shows that acute idiopathic pericarditis and pericarditis after heart surgical procedures cannot be differentiated by biochemical markers.

    Article  PubMed  Google Scholar 

  14. Ristić AD, Pankuweit S, Maksimović R, Moosdorf R, Maisch B. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev. 2013;18(3):345–53. https://doi.org/10.1007/s10741-012-9334-y.

    Article  CAS  PubMed  Google Scholar 

  15. Hammer Y, Bishara J, Eisen A, Iakobishvili Z, Kornowski R, Mager A. Seasonal patterns of acute and recurrent idiopathic pericarditis. Clin Cardiol. 2017;40(11):1152–5. https://doi.org/10.1002/clc.22804.

    Article  PubMed  Google Scholar 

  16. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350(6):586–97. https://doi.org/10.1056/NEJMra030840.

    Article  CAS  PubMed  Google Scholar 

  17. McClain MT, Harley JB, James JA. The role of Epstein-Barr virus in systemic lupus erythematosus. Front Biosci. 2001;6:E137–47 https://www.bioscience.org/2001/v6/e/mcclain/fulltext.htm.

    Article  CAS  Google Scholar 

  18. Cremer PC, Kumar A, Kontzias A, Tan CD, Rodriguez ER, Imazio M, et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol. 2016;68(21):2311–28. https://doi.org/10.1016/j.jacc.2016.07.785.

    Article  PubMed  Google Scholar 

  19. Yu L, Feng Z. The role of toll-like receptor signaling in the progression of heart failure. Mediat Inflamm. 2018;2018:9874109. https://doi.org/10.1155/2018/9874109.

    Article  CAS  Google Scholar 

  20. Coll RC, Holley CL, Schroder K. Mitochondrial DNA synthesis fuels NLRP3 activation. Cell Res. 2018;28(11):1046–7. https://doi.org/10.1038/s41422-018-0093-8.

    Article  PubMed  Google Scholar 

  21. Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560(7717):198–203. https://doi.org/10.1038/s41586-018-0372-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. https://doi.org/10.1038/nri3452.

    Article  CAS  PubMed  Google Scholar 

  23. Wallach D, Kang TB, Dillon CP, Green DR. Programmed necrosis in inflammation: Toward identification of the effector molecules. Science. 2016;352(6281):aaf2154. https://doi.org/10.1126/science.aaf2154.

    Article  CAS  PubMed  Google Scholar 

  24. Savva A, Roger T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol. 2013;4:387. https://doi.org/10.3389/fimmu.2013.00387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96(10):779–84. https://doi.org/10.1136/hrt.2009.187138.

    Article  CAS  PubMed  Google Scholar 

  26. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–53. https://doi.org/10.1016/0002-9343(67)90167-2.

    Article  CAS  PubMed  Google Scholar 

  27. French FMF Consortium, Bernot A, Clepet C, Dasilva C, Devaud C, Petit JL, et al. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17(1):25–31. https://doi.org/10.1038/ng0997-25.

    Article  Google Scholar 

  28. Balow JE Jr, Shelton DA, Orsborn A, Mangelsdorf M, Aksentijevich I, Blake T, et al. A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics. 1997;44(3):280–91. https://doi.org/10.1006/geno.1997.4860.

    Article  CAS  PubMed  Google Scholar 

  29. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9(7):473–83. https://doi.org/10.1038/sj.ejhg.5200658.

    Article  CAS  PubMed  Google Scholar 

  30. Booth DR, Gillmore JD, Lachmann HJ, Booth SE, Bybee A, Soytürk M, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93(4):217–21.

    Article  CAS  Google Scholar 

  31. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. 2016;75(4):644–51. https://doi.org/10.1136/annrheumdis-2015-208690.

    Article  CAS  PubMed  Google Scholar 

  32. Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, et al. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus. 2005;14(9):670–4. https://doi.org/10.1191/0961203305lu2197oa.

    Article  CAS  PubMed  Google Scholar 

  33. Okutur K, Seber S, Oztekin E, Bes C, Borlu F. Recurrent pericarditis as the initial manifestation of familial Mediterranean fever. Med Sci Monit. 2008;14(12):CS139–41 https://www.medscimonit.com/abstract/index/idArt/869467.

    PubMed  Google Scholar 

  34. • Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine. 2002;81(5):349–68. https://doi.org/10.1097/01.md.0000031361.64336.03 This review describes the concept of an autoinflammatory disease.

    Article  CAS  PubMed  Google Scholar 

  35. De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018;378(20):1908–19. https://doi.org/10.1056/NEJMoa1706314.

    Article  PubMed  Google Scholar 

  36. Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S, et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22(4):1051–8. https://doi.org/10.1177/039463200902200421.

    Article  CAS  PubMed  Google Scholar 

  37. Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F, et al. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol. 2012;101(7):525–31. https://doi.org/10.1007/s00392-012-0422-8.

    Article  CAS  PubMed  Google Scholar 

  38. Rowczenio DM, Trojer H, Omoyinmi E, Aróstegui JI, Arakelov G, Mensa-Vilaro A, et al. Brief report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome with Gonosomal Mosaicism of a novel 24-nucleotide TNFRSF1A deletion. Arthritis Rheumatol. 2016;68(8):2044–9. https://doi.org/10.1002/art.39683.

    Article  CAS  PubMed  Google Scholar 

  39. Cuisset L, Jeru I, Dumont B, Fabre A, Cochet E, Le Bozec J, et al. French CAPS study group. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis. 2011;70(3):495–9. https://doi.org/10.1136/ard.2010.138420.

    Article  CAS  PubMed  Google Scholar 

  40. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364(9447):1779–85. https://doi.org/10.1016/S0140-6736(04)17401-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lasigliè D, Mensa-Vilaro A, Ferrera D, Caorsi R, Penco F, Santamaria G, et al. Cryopyrin-associated periodic syndromes in Italian patients: evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization. J Rheumatol. 2017;44(11):1667–73. https://doi.org/10.3899/jrheum.170041.

    Article  CAS  PubMed  Google Scholar 

  42. Insalaco A, Prencipe G, Buonuomo PS, Ceccherini I, Bracaglia C, Pardeo M, et al. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes. Clin Exp Rheumatol. 2014;32(1):123–5 https://www.clinexprheumatol.org/article.asp?a=7018.

    PubMed  Google Scholar 

  43. Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM, et al. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin Arthritis Rheum. 2014;43(6):818–23. https://doi.org/10.1016/j.semarthrit.2013.12.002.

    Article  CAS  PubMed  Google Scholar 

  44. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012–6. https://doi.org/10.1161/CIRCULATIONAHA.105.542738.

    Article  CAS  PubMed  Google Scholar 

  45. • Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. ICAP investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522–8. https://doi.org/10.1056/NEJMoa1208536 This trial shows the efficacy of colchicine for acute pericarditis.

    Article  CAS  PubMed  Google Scholar 

  46. Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8:CD010652. https://doi.org/10.1002/14651858.CD010652.pub2.

    Article  Google Scholar 

  47. Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667–71. https://doi.org/10.1161/CIRCULATIONAHA.107.761064.

    Article  CAS  PubMed  Google Scholar 

  48. Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S, et al. Azathioprine in isolated recurrent pericarditis: a single Centre experience. Int J Cardiol. 2011;147(3):477–8. https://doi.org/10.1016/j.ijcard.2011.01.027.

    Article  PubMed  Google Scholar 

  49. Imazio M, Lazaros G, Picardi E, Vasileiou P, Carraro M, Tousoulis D, et al. Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases. J Cardiovasc Med. 2016;17(4):263–9. https://doi.org/10.2459/JCM.0000000000000260.

    Article  CAS  Google Scholar 

  50. Brucato A, Imazio M, Cremer PC, Adler Y, Maisch B, Lazaros G, et al. Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term. Intern Emerg Med. 2018;13(6):839–44. https://doi.org/10.1007/s11739-018-1907-x.

    Article  PubMed  Google Scholar 

  51. De Luca G, Cavalli G, Campochiaro C, Tresoldi M, Dagna L. Myocarditis: an Interleukin-1-mediated disease? Front Immunol. 2018;9:1335. https://doi.org/10.3389/fimmu.2018.01335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Scott IC, Hajela V, Hawkins PN, Lachmann HJ. A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis. J Cardiol Cases. 2011;4(2):e93–7. https://doi.org/10.1016/j.jccase.2011.07.003.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Lazaros G, Vasileiou P, Koutsianas C, Antonatou K, Stefanadis C, Pectasides D, et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis. 2014;73(12):2215–7. https://doi.org/10.1136/annrheumdis-2014-205990.

    Article  CAS  PubMed  Google Scholar 

  54. •• Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M, et al. Effect of Anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA. 2016;316(18):1906–12. https://doi.org/10.1001/jama.2016.15826 This trial shows the efficacy of anakinra for recurrent pericarditis.

    Article  PubMed  Google Scholar 

  55. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Canakinumab in CAPS study group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360(23):2416–25. https://doi.org/10.1056/NEJMoa0810787.

    Article  CAS  PubMed  Google Scholar 

  56. Kougkas N, Fanouriakis A, Papalopoulos I, Bertsias G, Avgoustidis N, Repa A, et al. Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. Rheumatology (Oxford). 2018;57(8):1494–5. https://doi.org/10.1093/rheumatology/key077.

    Article  Google Scholar 

  57. Unai S, Johnston DR. Radical Pericardiectomy for pericardial diseases. Curr Cardiol Rep. 2019;21(2):6. https://doi.org/10.1007/s11886-019-1092-1.

    Article  PubMed  Google Scholar 

  58. Gillaspie EA, Stulak JM, Daly RC, Greason KL, Joyce LD, Oh J, et al. A 20-year experience with isolated pericardiectomy: analysis of indications and outcomes. J Thorac Cardiovasc Surg. 2016;152(2):448–58. https://doi.org/10.1016/j.jtcvs.2016.03.098.

    Article  PubMed  Google Scholar 

  59. Nataf P, Cacoub P, Dorent R, Jault F, Bors V, Pavie A, et al. Results of subtotal pericardiectomy for constrictive pericarditis. Eur J Cardiothorac Surg. 1993;7(5):252–5. https://doi.org/10.1016/1010-7940(93)90213-U.

    Article  CAS  PubMed  Google Scholar 

  60. Maestroni S, Di Corato PR, Cumetti D, Chiara DB, Ghidoni S, Prisacaru L, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev. 2012;12(1):60–5. https://doi.org/10.1016/j.autrev.2012.07.023.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norbert Blank.

Ethics declarations

Conflict of Interest

Dr. Blank reports grants and personal fees from Novartis, grants and personal fees from SOBI, during the conduct of the study.

Hanns-Martin Lorenz declares no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Orphan Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blank, N., Lorenz, HM. Idiopathic Pericarditis—an Autoinflammatory Disease?. Curr Rheumatol Rep 21, 18 (2019). https://doi.org/10.1007/s11926-019-0820-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-019-0820-2

Keywords

Navigation